82 related articles for article (PubMed ID: 8859002)
21. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
22. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
23. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
Armstrong RA; Humphrey PP; Lumley P
Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
[TBL] [Abstract][Full Text] [Related]
25. EP 171: a high affinity thromboxane A2-mimetic, the actions of which are slowly reversed by receptor blockade.
Jones RL; Wilson NH; Lawrence RA
Br J Pharmacol; 1989 Apr; 96(4):875-87. PubMed ID: 2743082
[TBL] [Abstract][Full Text] [Related]
26. Gestational resistance to the pulmonary vasoconstrictor effect of the TxA2 mimetic U-46619: possible mechanism.
Losonczy G; Brown G; Mucha I; Klocke R; Muller V; Merkely B; Tornoci L; Rosivall L; Venuto R
Am J Physiol; 1997 Jun; 272(6 Pt 2):R1734-9. PubMed ID: 9227584
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclase.
Paul RV; Saxenhofer H; Wackym PS; Halushka PV
Am J Physiol; 1996 Jan; 270(1 Pt 2):F31-8. PubMed ID: 8769820
[TBL] [Abstract][Full Text] [Related]
28. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
Spurney RF; Onorato JJ; Albers FJ; Coffman TM
Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
[TBL] [Abstract][Full Text] [Related]
29. Thromboxane A2 analogue, U-46619, potentiates calcium-activated force in human umbilical artery.
Crichton CA; Templeton AG; McGrath JC; Smith GL
Am J Physiol; 1993 Jun; 264(6 Pt 2):H1878-83. PubMed ID: 8322917
[TBL] [Abstract][Full Text] [Related]
30. Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes.
Keith RA; Salama AI
Br J Pharmacol; 1987 Sep; 92(1):133-48. PubMed ID: 3664085
[TBL] [Abstract][Full Text] [Related]
31. Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors. Analysis of chimeric rat/human TP receptors.
Dorn GW; Davis MG; D'Angelo DD
J Biol Chem; 1997 May; 272(19):12399-405. PubMed ID: 9139686
[TBL] [Abstract][Full Text] [Related]
32. Characterization of human peripheral blood monocyte thromboxane A2 receptors.
Allan CJ; Halushka PV
J Pharmacol Exp Ther; 1994 Aug; 270(2):446-52. PubMed ID: 8071836
[TBL] [Abstract][Full Text] [Related]
33. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
Monshizadegan H; Hedberg A; Webb ML
Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
[TBL] [Abstract][Full Text] [Related]
34. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
36. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro.
Boersma JI; Janzen KM; Oliveira L; Crankshaw DJ
Br J Pharmacol; 1999 Dec; 128(7):1505-12. PubMed ID: 10602330
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the cloned HEL cell thromboxane A2 receptor: evidence that the affinity state can be altered by G alpha 13 and G alpha q.
Allan CJ; Higashiura K; Martin M; Morinelli TA; Kurtz DT; Geoffroy O; Meier GP; Gettys TW; Halushka PV
J Pharmacol Exp Ther; 1996 May; 277(2):1132-9. PubMed ID: 8627525
[TBL] [Abstract][Full Text] [Related]
38. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
Dorn GW
J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
[TBL] [Abstract][Full Text] [Related]
39. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
D'Angelo DD; Davis MG; Ali S; Dorn GW
J Pharmacol Exp Ther; 1994 Nov; 271(2):1034-41. PubMed ID: 7965765
[TBL] [Abstract][Full Text] [Related]
40. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
Webb ML; Liu EC; Monshizadegan H; Hedberg A; Misra RN; Goldenberg H; Harris DN
J Pharmacol Exp Ther; 1993 Mar; 264(3):1387-94. PubMed ID: 8450473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
